Last Updated: 18/09/2023
Humanized mouse in vivo assay platform at TAD
Objectives
The aim of this project is to identify novel therapeutics for malaria infection prevention and active case management in low and middle income countries (LIMC).
Principal Institution
Principal Investigators / Focal Persons
External reference
Thematic Categories
Date
Aug 2022 — Jul 2024
Total Project Funding
$725,636
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-038212
Project Site
Related Resources
